📰 Merck Sharp News
Page 122 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
The drug is most effective if taken within the first five days of suffering Covid-19.
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
The first anti-viral pill for Covid-19 that can be taken at home has been approved for use in the UK. Molnupiravir, developed by Ridgeback Biotherapeutics and M...
November 4, 2021
Molnupiravir effective at reducing the risk among patients with mild to moderate infection, health officials say
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
The first anti-viral pill for Covid-19 that can be taken at home has been approved for use in the UK. Molnupiravir, developed by Ridgeback Biotherapeutics and M...
November 4, 2021
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
November 4, 2021
Britain has become the first country to approve an antiviral COVID-19 treatment that can be taken as a ...
November 4, 2021
Antiviral drug Lagevrio (molnupiravir), developed by Ridgeback Biotherapeutics and Merck Sharp and Dohme (MSD), has been approved by the UK after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19